Pneumologia

DPOC

Triple inhaler therapy optimization, bronchoscopic lung volume reduction (Zephyr valves), and pulmonary rehab.

Opções de Tratamento

Centros Recomendados

$14,000

A partir de

7-21 dias

Espera Típica

Planos de Tratamento para DPOC

Compare opções baseadas em evidências nos principais hospitais chineses — preços transparentes, tempos de espera e recuperação.

Plano Principal

Bronchoscopic Lung Volume Reduction (Zephyr)

Endobronchial valve placement for severe emphysema with hyperinflation.

Tempo de Espera

14-21 days

Internação

5-7 days

Recuperação

4-6 weeks

Preço Estimado

Approx. $18,000

Ver Introdução Detalhada — Procedimento, Comparação de Preços e Mais

Comparação de Preços: China vs EUA

🇨🇳 China

$14,000

🇺🇸 EUA

$62,500+

Economize até $48,500 por tratamento

Etapas do Procedimento

Pre-op: HRCT chest + perfusion scan + 6MWT + fissure integrity assessment (Chartis)

Conscious sedation + local anesthetic spray to airway

Flexible bronchoscopy with target lobe identification

Chartis catheter assessment of collateral ventilation (CV-)

Sequential Zephyr valve deployment (3-5 valves per lobe)

Post-procedure observation for pneumothorax (highest risk Day 1-3)

Discharge Day 3-5 with chest X-ray monitoring

Pulmonary rehabilitation 6 weeks post-procedure

What are Zephyr Endobronchial Valves?

One-way valves placed bronchoscopically into the most diseased lobe of an emphysema lung, blocking inhaled air while allowing trapped air to escape. The hyperinflated lobe deflates, allowing healthier lobes to expand — essentially a non-surgical lung volume reduction.

Why China?

Cost: $25,000-$38,000 vs. $50,000-$90,000 in the US
NMPA approved: Pulmonx Zephyr valves available at top respiratory centers
No surgery: Bronchoscopic procedure, 3-5 day hospital stay
Reversible: Valves can be removed if needed

Who is a candidate?

Severe emphysema with hyperinflation (RV ≥175%, FEV1 15-50%)
Heterogeneous emphysema distribution
Intact interlobar fissures (CV-negative on Chartis)
Optimized medical therapy + pulmonary rehab

Outcomes

FEV1 improvement: 18-25%. 6MWT improvement: 30-40m. SGRQ quality of life improvement: clinically significant in 60-70%. Pneumothorax: 25-35% (most resolved with chest tube).

Agendar Consulta Gratuita WhatsApp

Os preços são faixas indicativas em USD baseadas nas tarifas publicadas. A cotação final depende dos seus registros médicos e hospital selecionado — solicite uma estimativa personalizada gratuita.